Arcus Biosciences Inc at JPMorgan Healthcare Conference Transcript
Okay. Welcome back to the 44th Annual JPMorgan Healthcare Conference. My name is Matt Bannon. I'm a banker here at JPM.
I'm very pleased to be introducing our next presenting company of the day, Arcus Biosciences. And on behalf of Arcus, we have the CEO, Terry Rosen.
Before we kick things off, I'll just remind folks that we will have a Q&A session. So just raise your hand, we'll get you a mic or you can ask it through the online portal, and I'll relay it on your behalf.
So without further ado, Terry?
Thanks. So good afternoon, everybody. Many of you are probably very familiar with Arcus and followed us for a long time, but hopefully, there's some new people, so what we thought we would do is start with a very brief overview of the company.
Arcus was founded about 10 years ago with basically a blank piece of paper with the notion of building an extraordinary small molecule
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
